PGGT1B and prostate cancer: Synergism between GGTIand docetaxel was observed across a broad range of concentrations.In conclusion, our results demonstrated that GGTI can inhibit thegrowth of prostate cancer cells and has synergistic effect withdocetaxel, suggesting its potential role in prostate cancertreatment.